Gapping down
In reaction to disappointing earnings/guidance:
- BOX -23.2%, FIT -15.9%, TDOC -15.8%, WIFI -14.6%, HPQ -14.5%, CROX -10.6%, ORBC -9.9%, BKNG -9.8%, PRAH -6.9%, HX -6.9%, SQ -6.1%, PK -5.9%, LB -5.7%, PDCE -5.7%, ITRI -5.6%, AYX -5.5%, ESTC -5.1%, WING -4.1%, SPAR -4.1%, PRGO -3.9%, PRTY -3.5% (also - CFO Dan Sullivan to leave the company effective March 22 to pursue other opportunities) LADR -3.3%, SEAS -3.2%, ABB -3%, AMED -2.8%, SJI -2.4%, SEMG -2.3%, AMRX -2.3%, SQM -2.2%, BTI -2.1%, ICPT -1.9%, SRPT -1.8%, FSK -1.8%, BGNE -1.8%, GPOR -1.4%, TD -1.3%, AKRX -1.3%
Other news:
- NVAX -66% (topline results from Phase 3 Prepare Trial of ResVax - did not meet primary objective)
- SYNH -27.9% (delayed its previously announced earnings release/call to allow additional time to complete its Form 10-K)
- AAOI -9.8% (announces proposed private offering of $70 mln aggregate principal amount of Convertible Senior Notes due 2024)
- CELG -7.8% (Bristol-Myers Squibb 8% shareholder Wellington Management says does not support proposed acquisition of Celgene)
- UNIT -6.6% (postpones Q4 release to assess the impact of the bankruptcy petition by Windstream Holdings)
- SKY -6.3% (prices secondary offering of 10,750,202 shares of its common stock by certain of its shareholders at $20.46 per share)
- KOS -5.6% (attributed to block trade pricing)
- ALDR -2.6% (prices offering of 11,304,348 shares of common stock at $11.50 per share)
- NOVT -1.6% (after closing 8% higher on the day; files for debt securities and common share shelf offering)
- EXPE -1.5% (following BKNG results)
- TRIP -1% (following BKNG results)
Analyst comments:
- CERN -3% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- BIG -2.1% (downgraded to Hold from Buy at Deutsche Bank)
- AMT -1.8% (downgraded to Perform from Outperform at Oppenheimer)
- VCEL -1.4% (downgraded to Hold from Buy at Needham)
- TREE -1.3% (downgraded to Neutral from Buy at UBS)
- TOL -1.2% (downgraded to In-line from Outperform at Evercore ISI)